Andrew Labelle
Impact in
-
- Antibiotic Use and Resistance
-
- Nosocomial Infections in ICU
Papers in
-
- Antibiotic Use and Resistance 5
-
- Nosocomial Infections in ICU 5
- Co-authors
- Marin H. KollefScott T. MicekHeather ArnoldRichard M. ReichleyNareg H. RoubinianSmita KothariMarya D. ZilberbergAndrew F. Shorr
- Journals
- Critical Care Medicine (3 papers)Clinics in Chest Medicine (1 paper)CHEST Journal (1 paper)BMC Infectious Diseases (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Andrew Labelle
9 papers receiving 589 citations
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 91
- Critical Care and Intensive Care Medicine 117
- Infectious Diseases 302
- Clinical Biochemistry 85
- Epidemiology 433
Countries citing papers authored by Andrew Labelle
This map shows the geographic impact of Andrew Labelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Labelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Labelle more than expected).
Fields of papers citing papers by Andrew Labelle
This network shows the impact of papers produced by Andrew Labelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Labelle. The network helps show where Andrew Labelle may publish in the future.
Co-authorship network
The 15 scholars most cited alongside Andrew Labelle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 2 | |
| 2 | 2012 | 59 | |
| 3 | 2012 | 1 | |
| 4 | 2011 | 8 | |
| 5 | 2010 | 132 | |
| 6 | 2010 | 104 | |
| 7 | 2010 | 82 | |
| 8 | 2009 | 74 | |
| 9 | 2008 | 144 |
About Andrew Labelle
Andrew Labelle is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Molecular Medicine, Epidemiology and Infectious Diseases, having authored 9 papers that have together received 606 indexed citations. Recurring topics across this work include Nosocomial Infections in ICU (5 papers), Antibiotic Use and Resistance (5 papers), Antifungal resistance and susceptibility (3 papers), Pneumonia and Respiratory Infections (3 papers), Cystic Fibrosis Research Advances (2 papers), Antibiotic Resistance in Bacteria (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (91 citations), Critical Care and Intensive Care Medicine (117 citations), Infectious Diseases (302 citations), Clinical Biochemistry (85 citations) and Epidemiology (433 citations). Andrew Labelle has collaborated with scholars based in United States and India. Frequent co-authors include Marin H. Kollef, Scott T. Micek, Heather Arnold, Richard M. Reichley, Nareg H. Roubinian, Smita Kothari, Marya D. Zilberberg, Andrew F. Shorr, Eli N. Deal and Kevin Heard. Their work appears in journals such as Critical Care Medicine, Clinics in Chest Medicine, CHEST Journal, BMC Infectious Diseases and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.